Up
Give feedback
  • Home
  • News
  • Health
  • Cystic fibrosis affects the respiratory and digestive systems, but modern treatment enables patients to lead full lives

Cystic fibrosis affects the respiratory and digestive systems, but modern treatment enables patients to lead full lives

Early diagnosis through neonatal screening and access to innovative modulators remain key challenges for Ukraine.

4 min for reading43 minutes ago
European Cystic Fibrosis Day on 21 November: symptoms, diagnosis and treatment European Cystic Fibrosis Day on 21 November: symptoms, diagnosis and treatment
Share:

Every year on 21 November, the European medical and patient community marks European Cystic Fibrosis Awareness Day, which was launched by the European Cystic Fibrosis Association (CF Europe). The main aim of this awareness campaign is to draw the attention of the public, governments and healthcare systems to the needs of people with rare (orphan) genetic conditions, to ensure equal access to the latest medicines and to support multidisciplinary care centres.

Cystic fibrosis is a severe hereditary condition caused by a mutation in the CFTR gene, which is responsible for the transport of chloride and sodium ions across cell membranes. As a result of this disorder, all secretions from the body’s exocrine glands become extremely thick and viscous. The bronchopulmonary system and the digestive organs, particularly the pancreas, are most severely affected.

How does the condition manifest itself, and why is neonatal screening important?

The condition is inherited in an autosomal recessive pattern: a child is born with cystic fibrosis only if they inherit one copy of the mutated gene from each parent, both of whom are healthy carriers. The build-up of thick mucus in the airways creates a favourable environment for chronic bacterial infections and inflammation, whilst blockage of the pancreatic ducts prevents food from being digested normally.

Experts identify the following as characteristic symptoms of the disease:

  • Respiratory symptoms: frequent, persistent cough with thick phlegm, shortness of breath, frequent recurrent bronchitis and pneumonia;
  • Digestive disorders: insufficient weight gain even with a good appetite, a deficiency in fat-soluble vitamins and specific bowel movement disorders;
  • ‘Salty’ sweat: an elevated concentration of chlorides in sweat, which historically served as the first sign for parents and formed the basis of the gold standard for diagnosis — the sweat test.

In Ukraine, cystic fibrosis is included in the state programme for extended neonatal screening of infants. Detecting the condition in the first weeks of life allows basic treatment to begin before irreversible changes develop in the lungs.

Modern treatment and support for Ukrainian patients

Just a few decades ago, cystic fibrosis was considered a disease affecting only children, with a poor prognosis; however, advances in medicine have radically changed the situation. Today, people with cystic fibrosis go to school, work, start families and live for decades, provided they receive continuous daily treatment, which includes:

  • Daily physiotherapy and inhalation treatments: special breathing exercises, mucolytics and antibacterial medicines to clear the bronchi of thick mucus;
  • Enzyme replacement therapy and a high-calorie diet: taking pancreatic enzymes with every meal to aid the absorption of nutrients;
  • Targeted therapy (CFTR modulators): innovative medicines that act directly on the cause of the disease — restoring the function of the defective protein at a cellular level, thereby significantly improving lung function and quality of life.

For Ukrainian patients with cystic fibrosis, the uninterrupted state provision of essential medicines, enzymes, inhalers and specialised therapeutic nutrition remains critically important during the war, as does the maintenance of the electricity supply, on which the daily operation of medical compressor-driven nebulisers depends.

This material is intended solely for informational and educational purposes and does not contain any medical advice, diagnosis or treatment recommendations. If you suspect a hereditary condition, have a chronic cough, or require treatment to be prescribed or adjusted, you must consult the relevant specialist — a GP, a pulmonologist or a medical geneticist.

Read more news on GreenPost.

Follow GreenPost on Facebook. Subscribe to us at Telegram.